Skip to main content

ADVERTISEMENT

exemestane

Research in Review
02/23/2017
JCP Editors
Women with breast cancer are more likely to discontinue chemoprevention therapy if menopause-specific symptoms negatively impact their quality of life (QOL), according to a study published in the Journal of Clinical...
Women with breast cancer are more likely to discontinue chemoprevention therapy if menopause-specific symptoms negatively impact their quality of life (QOL), according to a study published in the Journal of Clinical...
Women...
02/23/2017
Journal of Clinical Pathways